Completed
PSMA-PET Imaging for Advanced ACC/SDC
NCT03319641
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +13 more
- Locations
-
- Radboudumc Nijmegen, Gelderland, Netherlands
Clinical trial condition
Adenoid Cystic Carcinoma
Explore clinical trials studying Adenoid Cystic Carcinoma. Study availability and eligibility vary by location and protocol.
43 public trials
16 recruiting studies
Adenoid Cystic Carcinoma trial results
Completed
Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT01558661
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +10 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02662608
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00581360
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- UPMC Cancer Center - Teramana Cancer Center - Steubenville Steubenville, Ohio, United States
- UPMC Cancer Center - Beaver Beaver, Pennsylvania, United States
- UPMC Cancer Center - Clairton Clairton, Pennsylvania, United States
- UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg Greensburg, Pennsylvania, United States
Completed
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
NCT00886132
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +18 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT01152840
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Completed
Dovitinib in Adenoid Cystic Carcinoma
NCT01417143
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- Department of Internal Medicine, Seoul National University Hospital Seoul, South Korea
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
NCT04895735
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +14 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
NCT02780310
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States